Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancer (Breast Cancer Res Treat, (2016), 155, (165-173), 10.1007/s10549-015-3658-y)

Kenneth L. Kehl; Chan Shen; Jennifer K. Litton; Banu Arun; Sharon H. Giordano

doi:10.1007/s10549-016-3922-9

Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancer (Breast Cancer Res Treat, (2016), 155, (165-173), 10.1007/s10549-015-3658-y)

Kenneth L. Kehl, Chan Shen, Jennifer K. Litton, Banu Arun, Sharon H. Giordano

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original publication of the article, the first sentence in the last paragraph of second page was published erroneously as, “We identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S1818–S1823, as previously described [8].” The correct sentence should read as, ȁWe identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S3818–S3823, as previously described [8].” The authors regret this error.

Original language	English (US)
Number of pages	1
Journal	Breast Cancer Research and Treatment
Volume	159
Issue number	1
DOIs	https://doi.org/10.1007/s10549-016-3922-9
State	Published - Aug 1 2016

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10549-016-3922-9

Cite this

@article{ed38c75950a64dcf82574d2d6b985191,

title = "Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancer (Breast Cancer Res Treat, (2016), 155, (165-173), 10.1007/s10549-015-3658-y)",

abstract = "In the original publication of the article, the first sentence in the last paragraph of second page was published erroneously as, “We identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S1818–S1823, as previously described [8].” The correct sentence should read as, ȁWe identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S3818–S3823, as previously described [8].” The authors regret this error.",

author = "Kehl, {Kenneth L.} and Chan Shen and Litton, {Jennifer K.} and Banu Arun and Giordano, {Sharon H.}",

year = "2016",

month = aug,

day = "1",

doi = "10.1007/s10549-016-3922-9",

language = "English (US)",

volume = "159",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer New York",

number = "1",

}

TY - JOUR

T1 - Erratum to

T2 - Rates of BRCA1/2 mutation testing among young survivors of breast cancer (Breast Cancer Res Treat, (2016), 155, (165-173), 10.1007/s10549-015-3658-y)

AU - Kehl, Kenneth L.

AU - Shen, Chan

AU - Litton, Jennifer K.

AU - Arun, Banu

AU - Giordano, Sharon H.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - In the original publication of the article, the first sentence in the last paragraph of second page was published erroneously as, “We identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S1818–S1823, as previously described [8].” The correct sentence should read as, ȁWe identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S3818–S3823, as previously described [8].” The authors regret this error.

AB - In the original publication of the article, the first sentence in the last paragraph of second page was published erroneously as, “We identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S1818–S1823, as previously described [8].” The correct sentence should read as, ȁWe identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S3818–S3823, as previously described [8].” The authors regret this error.

UR - http://www.scopus.com/inward/record.url?scp=84979985983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979985983&partnerID=8YFLogxK

U2 - 10.1007/s10549-016-3922-9

DO - 10.1007/s10549-016-3922-9

M3 - Comment/debate

AN - SCOPUS:84979985983

SN - 0167-6806

VL - 159

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 1

ER -

Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancer (Breast Cancer Res Treat, (2016), 155, (165-173), 10.1007/s10549-015-3658-y)

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this